Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus-Reference-Cited by-同舟云学术

Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus

Published:2003-10-20 Issue:9 Volume:171 Page:4898-4904
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Karanikas Vaios,Lurquin Christophe,Colau Didier,van Baren Nicolas,De Smet Charles,Lethé Bernard,Connerotte Thierry,Corbière Véronique,Demoitié Marie-Ange,Liénard Danielle,Dréno Brigitte,Velu Thierry,Boon Thierry,Coulie Pierre G.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference24 articles.

1. A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

2. Boon, T., B. Van den Eynde. 2000. Cancer vaccines: cancer antigens, shared tumor-specific antigens. S. A. Rosenberg, ed. Principles and Practice of the Biologic Therapy of Cancer 493. Lippincott Williams & Wilkins, Philadelphia.

3. Expression ofMAGE genes in primary and metastatic cutaneous melanoma

4. Tumor-specific shared antigenic peptides recognized by human T cells

5. Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+ T Lymphocytes

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A synthetic cytotoxic T cell platform for rapidly prototyping TCR function;npj Precision Oncology;2024-08-19

2. A Synthetic Cytotoxic T cell Platform for Rapidly Prototyping TCR Function;2023-11-30

3. A Synthetic Cytotoxic T cell Platform for Rapidly Prototyping TCR Function;2023-11-21

4. High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity;Immunity;2022-10

5. Current status of virus-vectored vaccines against pathogens that affect poultry;Vaccine;2020-10